Some vaccines have trace levels of thimerosal left over from the manufacturing process (less than 1 µg thimerosal per 0.5 mL dose of vaccine), [25] an amount that is considered insignificant.

GMTs were higher (P =0.02) for children receiving vaccine on the 0-, 1-, and 6-month schedule compared with those on the 0-, 12-, and 24-month schedule (5687 mIU/mL vs 3159 mIU/mL, respectively).

The Ministry of Health has approved Moderna's updated COVID vaccines, which target the new JN1 variant of the virus.

For other vaccine antigens, namely ... Intergroup Comparison* Noninferiority Margin Diphtheria 0.01–0.1 IU/mL % of subjects with antidiphtheria antibodies ≥0.1 IU/ml (≥1.0 IU/mL in ...

Revaccination at 12 months with the investigational respiratory syncytial virus (RSV) vaccine mRNA-1345 is well tolerated and supported for eligible older adults, according to study results presented ...

HAV vaccination was highly immunogenic among virologically suppressed patients with HIV and those on immunosuppressive monotherapy.

The cold and flu are respiratory illnesses caused by different viruses. Some cold and flu symptoms may overlap, but there are ...

Ever since recombinant DNA has been used to develop and manufacture vaccines, antivaxxers have portrayed it as evil. This ...

Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to ...

“ML is improving customer experience, creating more efficiencies in operations and spurring new innovations and discoveries like helping researchers discover new vaccines and enhancing ...